Heron Therapeutics, Inc. (HRTX)
PHARMACEUTICAL PREPARATIONS
Heron Therapeutics, Inc. (HRTX) is listed on Nasdaq, where it has traded since August 27, 1987.
- Listed On
- Nasdaq
- Listed Since
- August 27, 1987
- Employees
- 128
- Market Cap
- $58M
About Heron Therapeutics, Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 156 institutions reported holding HRTX, with 133.7 million shares worth $57.2 million in aggregate. The largest reported holder was Rubric Capital Management, with 30.0 million shares worth $12.8 million. Of the 5 largest holders listed below, 2 added shares, 1 reduced its position and 2 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Rubric Capital Management | 30,046,828 | $13M | Unchanged |
| Clearline Capital | 11,383,961 | $5M | Reduced 6.96% |
| Vanguard | 10,839,402 | $5M | Added 4.53% |
| BlackRock | 10,550,750 | $5M | Added 4.4% |
| Velan Capital Investment Management | 8,753,290 | $4M | Unchanged |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is HRTX?
Heron Therapeutics, Inc. (HRTX) is listed on Nasdaq, where it has traded since August 27, 1987.
Who are the largest institutional holders of HRTX?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of HRTX were Rubric Capital Management, Clearline Capital and Vanguard.
How many institutions own HRTX?
156 institutions reported a position in HRTX for the quarter ended June 30, 2026, worth $57.2 million in total.
Did institutions buy or sell HRTX last quarter?
Of the 5 largest reported holders, 2 added shares, 1 reduced its position and 2 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for HRTX.
Every reported institutional holder, plus insider and congressional trades in HRTX, on SentiSense.